Sirus Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

Sirus General Information

Description

Operator of a pharmaceutical research company. The company focuses on drug development for the treatment of nerve injury and muscle spasm by using its proprietary platform technologies that covers pain, emesis, epilepsy and insomnia.

Contact Information

Formerly Known As
SynGenix
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Babraham Hall
  • Babraham
  • Cambridge CB2 4AT
  • England, United Kingdom
+44 01223
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Babraham Hall
  • Babraham
  • Cambridge CB2 4AT
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sirus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Mar-2004 Completed Generating Revenue
2. Later Stage VC 11-Sep-2001 Completed Generating Revenue
1. Later Stage VC 01-Jan-1998 $2.49M $2.49M Completed Generating Revenue
To view Sirus’s complete valuation and funding history, request access »

Sirus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sirus Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Research and Innovation Venture Capital Minority
Providence Investment Management Asset Manager Minority
Science Group Corporation Minority
Technomark Medical Ventures Venture Capital Minority
World Life Sciences Other Minority
You’re viewing 5 of 6 investors. Get the full list »

Sirus FAQs

  • When was Sirus founded?

    Sirus was founded in 1992.

  • Where is Sirus headquartered?

    Sirus is headquartered in Cambridge, United Kingdom.

  • What is the size of Sirus?

    Sirus has 20 total employees.

  • What industry is Sirus in?

    Sirus’s primary industry is Biotechnology.

  • Is Sirus a private or public company?

    Sirus is a Private company.

  • What is Sirus’s current revenue?

    The current revenue for Sirus is .

  • How much funding has Sirus raised over time?

    Sirus has raised $9.7M.

  • Who are Sirus’s investors?

    Cambridge Research and Innovation, Providence Investment Management, Science Group, Technomark Medical Ventures, and World Life Sciences are 5 of 6 investors who have invested in Sirus.

  • When was Sirus acquired?

    Sirus was acquired on 01-Mar-2004.

  • Who acquired Sirus?

    Sirus was acquired by Arakis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process